- Home
- Companies
- north america
- heart failure treatments
Show results for
Refine by
Heart Failure Treatments Suppliers In North America
6 companies found
based inSan Francisco, CALIFORNIA (USA)
ViCardia Therapeutics, Inc., a Delaware corporation, founded in 2017, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies for treating heart failure (HF) involving ...
based inSanta Clara, CALIFORNIA (USA)
Ancora Heart is dedicated to providing new treatment options for patients suffering from heart failure. Our team has a deep appreciation for the challenges faced by the estimated 26 million patients across the globe who are living with this chronic, ...
based inCaesarea Industrial Park (N), ISRAEL
V-WAVE was established in Israel in 2009 with a focus on developing percutaneous implantable technologies for patients with chronic heart failure. Technology designed by V-Wave, highlighted by its Ventura Interatrial Shunt System, was designed to ...
Heart failure (HF) is a condition where the heart is not pumping enough blood to meet the needs of the body. When heart failure occurs, there is an increase in pressure in the heart and lungs, plus fluid build-up in the lungs. The fluid causes ...
based inSunnyvale, CALIFORNIA (USA)
EBR Systems, Inc. was founded in 2003 to develop an implantable system for wireless tissue stimulation, with an initial focus on addressing well-recognized shortcomings in treating heart failure with Cardiac Resynchronization Therapy (CRT). Based on ...
based inAustin, TEXAS (USA)
Windmill Cardiovascular Systems has developed a revolutionary blood pump for treating patients with heart failure. The unique design promises to improve patient outcomes with gentle blood handling and pulsatile ...
based inSan Diego, CALIFORNIA (USA)
Everyone at AnaBios shares a passion and commitment to make a difference in the development of promising new therapies and cures for patients by reducing the time and expense needed to bring these medicines to patients. We do this by generating ...
CardioPRIME® is the AnaBios approach for measuring human cardiomyocyte functionality and sets the industry standard for cardiac-based biomedical research. By leveraging the robust excitation-contraction coupling of mature primary human ...